| Korey Johnson, MD | |
|
1701 N George Mason Dr Ste 2d, Arlington, VA 22205-3610 | |
| (703) 558-2438 | |
| Not Available |
| Full Name | Korey Johnson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1701 N George Mason Dr Ste 2d, Arlington, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891223053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A166553 (California) | Secondary |
| 207L00000X | Anesthesiology | 0101277077 (Virginia) | Primary |
| Entity Name | Dominion Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073554952 PECOS PAC ID: 7618863713 Enrollment ID: O20040305000503 |
News Archive
The Partnership for a Drug-Free America is proud to have David Sheff, parent and author of "Beautiful Boy: A Father's Journey Through His Son's Addiction," as a guest blogger on the Partnership's parent-to-parent blog, Decoder (decoder.drugfree.org), which engages the everyday issues of raising healthy, drug-free teens.
A recent short report from Canada, currently available on medRxiv* preprint server, shows a rapid increase in severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) cases characterized by the N501Y-/E484K- mutation in the Ontario province, which implies that Delta variant will rapidly overtake the Alpha variant.
News outlets report on recent developments — such as patients billing physicians for the time they spend waiting and how doctors are seeking help in dealing with difficult patients.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.
Drugmaker GlaxoSmithKline (GSK)'s Chief Executive Officer Andrew Witty on Tuesday unveiled the company's plans to allow "free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries," Bloomberg reports (Randall, 1/20).
› Verified 8 days ago
| Entity Name | Holy Cross Anesthesiology Associate, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376501007 PECOS PAC ID: 3577454313 Enrollment ID: O20040322001776 |
News Archive
The Partnership for a Drug-Free America is proud to have David Sheff, parent and author of "Beautiful Boy: A Father's Journey Through His Son's Addiction," as a guest blogger on the Partnership's parent-to-parent blog, Decoder (decoder.drugfree.org), which engages the everyday issues of raising healthy, drug-free teens.
A recent short report from Canada, currently available on medRxiv* preprint server, shows a rapid increase in severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) cases characterized by the N501Y-/E484K- mutation in the Ontario province, which implies that Delta variant will rapidly overtake the Alpha variant.
News outlets report on recent developments — such as patients billing physicians for the time they spend waiting and how doctors are seeking help in dealing with difficult patients.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.
Drugmaker GlaxoSmithKline (GSK)'s Chief Executive Officer Andrew Witty on Tuesday unveiled the company's plans to allow "free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries," Bloomberg reports (Randall, 1/20).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Korey Johnson, MD 1701 N George Mason Dr Ste 2d, Arlington, VA 22205-3610 Ph: (703) 558-2438 | Korey Johnson, MD 1701 N George Mason Dr Ste 2d, Arlington, VA 22205-3610 Ph: (703) 558-2438 |
News Archive
The Partnership for a Drug-Free America is proud to have David Sheff, parent and author of "Beautiful Boy: A Father's Journey Through His Son's Addiction," as a guest blogger on the Partnership's parent-to-parent blog, Decoder (decoder.drugfree.org), which engages the everyday issues of raising healthy, drug-free teens.
A recent short report from Canada, currently available on medRxiv* preprint server, shows a rapid increase in severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) cases characterized by the N501Y-/E484K- mutation in the Ontario province, which implies that Delta variant will rapidly overtake the Alpha variant.
News outlets report on recent developments — such as patients billing physicians for the time they spend waiting and how doctors are seeking help in dealing with difficult patients.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.
Drugmaker GlaxoSmithKline (GSK)'s Chief Executive Officer Andrew Witty on Tuesday unveiled the company's plans to allow "free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries," Bloomberg reports (Randall, 1/20).
› Verified 8 days ago
Robert Minh Cao Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1860 N Scott St Apt 639, Arlington, VA 22209 Phone: 337-534-9256 | |
Dr. Mushfique Ahmed, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-2438 | |
Dr. Krupa Bipin Patel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr Ste 2d, Arlington, VA 22205 Phone: 703-558-2438 | |
Marina Pavlova, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Arlington, VA 22205 Phone: 703-558-5000 | |
John M Huffman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1635 N George Mason Dr Ste 150, Arlington, VA 22205 Phone: 571-732-0044 Fax: 866-850-1049 | |
Ashley Tran, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1701 N George Mason Dr Ste 2d, Arlington, VA 22205 Phone: 703-558-2438 | |
Dr. Peter Glass, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1525 Wilson Blvd Ste 540, Arlington, VA 22209 Phone: 202-315-5223 |